Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement

NCT00641732 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1045

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: TAK-442
DRUG: TAK-442
DRUG: TAK-442
DRUG: TAK-442
DRUG: TAK-442
DRUG: TAK-442
DRUG: Enoxaparin

Sponsor

Takeda